CA2263297A1 - Inhibiting undesirable taste in oral compositions - Google Patents

Inhibiting undesirable taste in oral compositions

Info

Publication number
CA2263297A1
CA2263297A1 CA002263297A CA2263297A CA2263297A1 CA 2263297 A1 CA2263297 A1 CA 2263297A1 CA 002263297 A CA002263297 A CA 002263297A CA 2263297 A CA2263297 A CA 2263297A CA 2263297 A1 CA2263297 A1 CA 2263297A1
Authority
CA
Canada
Prior art keywords
oral compositions
undesirable taste
oral
inhibiting undesirable
undesirable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002263297A
Other languages
French (fr)
Other versions
CA2263297C (en
Inventor
Sandra Lynn Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
The Procter & Gamble Company
Sandra Lynn Nelson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company, Sandra Lynn Nelson filed Critical The Procter & Gamble Company
Publication of CA2263297A1 publication Critical patent/CA2263297A1/en
Application granted granted Critical
Publication of CA2263297C publication Critical patent/CA2263297C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/21—Synthetic spices, flavouring agents or condiments containing amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Abstract

The present invention relates to a method for inhibiting an undesirable taste in oral compositions such as foods, beverages, and pharmaceuticals. The present invention also relates to oral and pharmaceutical compositions comprising undesirable tasting compounds wherein undesirable tastes are inhibited by the addition of a phosphorylated amino acid, such as phosphotyrosine, phosphoserine, phosphothreonine, and mixtures thereof, to said oral and pharmaceutical compositions.
CA002263297A 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions Expired - Fee Related CA2263297C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/696,711 US5766622A (en) 1996-08-14 1996-08-14 Inhibiting undesirable taste in oral compositions
US08/696,711 1996-08-14
PCT/US1997/013472 WO1998006436A2 (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions

Publications (2)

Publication Number Publication Date
CA2263297A1 true CA2263297A1 (en) 1998-02-19
CA2263297C CA2263297C (en) 2003-10-28

Family

ID=24798232

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002263297A Expired - Fee Related CA2263297C (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions

Country Status (21)

Country Link
US (1) US5766622A (en)
EP (1) EP1077726B1 (en)
JP (1) JP2001527518A (en)
KR (1) KR100323271B1 (en)
CN (1) CN1306440A (en)
AR (1) AR009079A1 (en)
AT (1) ATE234115T1 (en)
AU (1) AU724235B2 (en)
BR (1) BR9711159A (en)
CA (1) CA2263297C (en)
CO (1) CO4920235A1 (en)
CZ (1) CZ48199A3 (en)
DE (1) DE69719827T2 (en)
HU (1) HUP0103016A3 (en)
ID (1) ID19356A (en)
IL (1) IL128488A0 (en)
NO (1) NO990685L (en)
PE (1) PE100598A1 (en)
TR (1) TR199900300T2 (en)
WO (1) WO1998006436A2 (en)
ZA (1) ZA977082B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6816934B2 (en) * 2000-12-22 2004-11-09 Hewlett-Packard Development Company, L.P. Computer system with registered peripheral component interconnect device for processing extended commands and attributes according to a registered peripheral component interconnect protocol
US6169118B1 (en) 1998-11-12 2001-01-02 Block Drug Company, Inc. Flavor blend for masking unpleasant taste of zinc compounds
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
AU2001271544A1 (en) * 2000-06-30 2002-01-14 The Procter And Gamble Company Oral compositions comprising host-response modulating agent
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
ITMI20012135A1 (en) * 2001-10-16 2003-04-16 Bioren S A INJECTABLE SOLUTIONS READY TO USE PARACETAMOL
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
US6908637B2 (en) 2002-04-26 2005-06-21 Kraft Foods Holdings, Inc. Process for debittering peanut hearts
US7081264B2 (en) 2002-04-26 2006-07-25 Kraft Foods Holdings, Inc. Process for debittering peanut hearts
US20040091544A1 (en) * 2002-11-08 2004-05-13 Ruff Michael D. Coated dibasic calcium phosphate
CL2003002653A1 (en) * 2002-12-18 2005-04-22 Wyeth Corp PHARMACEUTICAL COMPOSITION THAT INCLUDES (A) AN NON-STEROID ANTI-INFLAMMATORY (NSAID), PREFERREDLY IBUPROFEN, (B) A DECONGESTIONANT, PREFERENTIALLY PSEUDOEFEDRINE AND (C) AN ANTIHISTAMINIC, PREFERENTLY CHLORINE; METHOD FOR YOUR PREPARATION
JP2006518751A (en) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド Novel formulation for rapid and sustained suppression of gastric acid, omeprazole antacid complex-immediate release
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20050084587A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Ice creams comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084589A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Dressings comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084600A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Dips comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084591A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Soups comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050238785A1 (en) * 2003-10-20 2005-10-27 Circle Group Holdings, Inc. Sauces comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP4435544B2 (en) 2003-11-19 2010-03-17 高砂香料工業株式会社 Fruit juice-containing beverage
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
BRPI0508335B1 (en) * 2004-02-26 2019-09-03 Wrigley W M Jun Co sweets and chewing gum containing physiological cooling agents
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050287275A1 (en) * 2004-06-28 2005-12-29 Shukla Triveni P Sauces comprising dietary fiber gel
US20050287273A1 (en) * 2004-06-28 2005-12-29 Shukla Triveni P Processed cheeses comprising dietary fiber gel
US20060286268A1 (en) * 2005-06-14 2006-12-21 Circle Group Holdings, Inc. Amorphous insoluble cellulosic fiber and method for making same
US20070098815A1 (en) * 2005-10-27 2007-05-03 Bernstein Lawrence R Orally Administrable Gallium Compositions and Methods of Use
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20070207206A1 (en) * 2006-03-02 2007-09-06 Rice Bronwyn C Chewable pain formula
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions
EP2742350B1 (en) 2011-08-08 2019-10-30 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
US20160089439A1 (en) * 2014-09-28 2016-03-31 Satara Pharmaceuticals, LLC Prevention of Illicit Manufacutre of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients
EP4142520A1 (en) * 2020-04-29 2023-03-08 Société des Produits Nestlé S.A. A nutritional product containing a buffer composition and an amino acid and methods of using such a nutritional product

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US4031265A (en) * 1975-06-18 1977-06-21 The United States Of America As Represented By The Secretary Of Agriculture Method of reducing bitterness in citrus juices
US4248141A (en) * 1978-08-18 1981-02-03 Miller Jr Harry W Method and apparatus for debittering soybeans
CH635732A5 (en) * 1979-01-26 1983-04-29 Nestle Sa PROCESS FOR DEAMERIZING A FRUIT OR VEGETABLE EXTRACT AND DESAMERIZED EXTRACT OBTAINED.
JPS56158707A (en) * 1980-04-08 1981-12-07 Lion Corp Composition for oral use
NZ199891A (en) * 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4517379A (en) * 1981-06-26 1985-05-14 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
JPS59104310A (en) * 1982-12-07 1984-06-16 Lion Corp Composition for oral cavity
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US5192563A (en) * 1986-10-22 1993-03-09 Wm. Wrigley, Jr. Company Strongly mint-flavored chewing gums with reduced bitterness and harshness
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
US4994490A (en) * 1989-04-03 1991-02-19 The Nutrasweet Company Novel N-(sulfomethyl)-N'-arylureas
US5266717A (en) * 1989-04-03 1993-11-30 Glenn Roy N-(sulfomethyl)-N'arylureas
JPH0354921A (en) * 1989-07-24 1991-03-08 Nec Corp Squelch signal generating circuit
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
JPH049335A (en) * 1990-04-25 1992-01-14 Aamu:Kk Method for removing bitterness and astringency of gymnema-sylvestre and beverage thereof
US5232735A (en) * 1990-06-01 1993-08-03 Bioresearch, Inc. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
CA2094060A1 (en) * 1990-10-15 1992-04-16 Toshifumi Asaka 2'-position modified compound of erythromycin or its derivative
JP3246738B2 (en) * 1990-11-30 2002-01-15 ロート製薬株式会社 Saponin and amino acid-containing composition
US5336513A (en) * 1991-02-20 1994-08-09 Kraft General Foods, Inc. Bitterness inhibitors
JPH0515389A (en) * 1991-07-12 1993-01-26 Terumo Corp Production of protein-like composition
DE4131118A1 (en) * 1991-09-19 1993-03-25 Henkel Kgaa METHOD FOR PRODUCING TASTE-NEUTRAL PASTS OF ALKYL ETHER SULFATES IN GLYCERINE
JPH0584288A (en) * 1991-09-25 1993-04-06 Terumo Corp Wound coating material
CZ129094A3 (en) * 1991-11-27 1995-12-13 Bioresearch Specific edible modifiers of taste
DE4200821A1 (en) * 1992-01-15 1993-07-22 Bayer Ag TASTE-MASKED PHARMACEUTICAL AGENTS
JP2615345B2 (en) * 1992-12-28 1997-05-28 三栄源エフ・エフ・アイ株式会社 Taste improving agent and taste improving method
EP0635218B1 (en) * 1993-02-05 2000-10-25 Kao Corporation Taste modifying method and bitter taste reducing method
US5407921A (en) * 1993-07-01 1995-04-18 Kao Corporation Method for suppressing bitter taste

Also Published As

Publication number Publication date
JP2001527518A (en) 2001-12-25
NO990685L (en) 1999-04-12
HUP0103016A2 (en) 2001-12-28
CZ48199A3 (en) 1999-06-16
AU724235B2 (en) 2000-09-14
NO990685D0 (en) 1999-02-12
PE100598A1 (en) 1999-01-06
ATE234115T1 (en) 2003-03-15
KR20000030006A (en) 2000-05-25
ZA977082B (en) 1998-03-04
WO1998006436A2 (en) 1998-02-19
WO1998006436A3 (en) 2000-12-21
AU3967697A (en) 1998-03-06
DE69719827D1 (en) 2003-04-17
TR199900300T2 (en) 1999-06-21
US5766622A (en) 1998-06-16
KR100323271B1 (en) 2002-02-06
BR9711159A (en) 1999-08-17
EP1077726B1 (en) 2003-03-12
CN1306440A (en) 2001-08-01
ID19356A (en) 1998-07-02
HUP0103016A3 (en) 2002-06-28
DE69719827T2 (en) 2003-12-24
AR009079A1 (en) 2000-03-08
EP1077726A2 (en) 2001-02-28
CA2263297C (en) 2003-10-28
IL128488A0 (en) 2000-01-31
CO4920235A1 (en) 2000-05-29

Similar Documents

Publication Publication Date Title
CA2263297A1 (en) Inhibiting undesirable taste in oral compositions
CA2361681A1 (en) Method of enhancing salty taste, salty taste enhancer, salty taste seasoning agent and salty taste-enhanced foods
CA2383983A1 (en) Substituted indolealkanoic acids
CA2387738A1 (en) Process for producing a product containing antihypertensive tripeptides
CA2327285A1 (en) Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
CA2183371A1 (en) Pna combinatorial libraries and improved methods of synthesis
CA2216535A1 (en) Protein kinase c inhibitors
WO1998028268A3 (en) CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
WO1998022494A3 (en) METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS
AU5249898A (en) N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
CA2437770A1 (en) Coffee compositions with enhanced flavor characteristics and method of making
CA2197106A1 (en) A mayonnaise-like product and a process for its manufacture
CA2150251A1 (en) Lyospheres comprising gonadotropin
ZA971850B (en) New aryl glycine amide derivatives, processes for preparing them and pharmaceutical compositions containing these compounds.
HUP9800049A3 (en) Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
CA2263328A1 (en) Use of .gamma.-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
WO1998022441A3 (en) N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
WO1998019697A3 (en) Novel pharmaceutical compositions
EP0791601A3 (en) An agent promoting bone formation and inhibiting bone resorption
HUP9601321A2 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
CA2013772A1 (en) N-(sulfomethyl)-n'-arylureas
CA2273277A1 (en) The use of oligosaccharides to increase the sweetness and improve the taste of an acesulfame-k/aspartame mixture
AU5493298A (en) Stabilized pharmaceutical compositions and process for the preparation thereof
ZA975330B (en) Process for the preparation of chiral keto-heterocycles of basic amino acids.
AU5819296A (en) Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed